Results of a multicentre pilot study
Hydrate Smarter This Summer Support hydration from the inside out Hot weather, travel, exercise, and everyday stress can increase your body's demand for fluids and minerals
The following table describes GLP-1 receptor agonists, their dosing frequency and key pharmacokinetic parameters: Cautions and Contraindications Adverse Effects Acute pancreatitis (rare) Injection site reactions Gastrointestinal disturbances (nausea, vomiting, diarrhoea dehydration and possible renal impairment) Increase in pancreatic enzymes: lipase and amylase (dulaglutide, tirzepatide and semaglutide) Cholecystitis and cholelithiasis Delayed gastric emptying (semaglutide, exenatide, dulaglutide, tirzepatide (diminishes over time)) Increased heart rate Diabetic retinopathy complications (semaglutide, particularly in insulin-treated patients with known diabetic retinopathy) Interactions GLP-1 receptor agonists do not interact via cytochrome P450 , but delayed gastric emptying may alter drug absorption
You have had a proper consultation and are suitable for this style of treatment
Like its counterparts, Trulicity often triggers nausea and intestinal issues as side effects
This protocol recommends weekly B12/MIC injections for up to 6-months (or 6 total refills)
